Total Payments
$12,817
2024 Payments
$1,919
Companies
48
Transactions
848
Medicare Patients
49,614
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$12,703 (99.1%)
Education$114.05 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,703 | 843 | 99.1% |
| Education | $114.05 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,872 | 186 | $0 (2024) |
| Lilly USA, LLC | $887.67 | 72 | $0 (2024) |
| Novo Nordisk Inc | $826.75 | 88 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $715.89 | 53 | $0 (2024) |
| Amgen Inc. | $649.49 | 38 | $0 (2023) |
| Astellas Pharma US Inc | $630.99 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $585.82 | 47 | $0 (2024) |
| PFIZER INC. | $438.02 | 41 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $409.19 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $396.91 | 38 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,919 | 112 | ABBVIE INC. ($854.67) |
| 2023 | $1,968 | 111 | AbbVie Inc. ($860.76) |
| 2022 | $2,818 | 166 | ABBVIE INC. ($1,327) |
| 2021 | $1,985 | 125 | AbbVie Inc. ($811.97) |
| 2020 | $500.15 | 33 | Allergan, Inc. ($224.95) |
| 2019 | $1,268 | 111 | GlaxoSmithKline, LLC. ($168.39) |
| 2018 | $1,209 | 96 | Boehringer Ingelheim Pharmaceuticals, Inc. ($144.39) |
| 2017 | $1,149 | 94 | Merck Sharp & Dohme Corporation ($178.36) |
All Payment Transactions
848 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Biological | ||||||
| 12/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: UROLOGY | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Biological | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Endocrinology | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $10.21 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.68 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Iron Deficiency Anemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 53 | 13,422 | 19,334 | $1.4M | $628,205 |
| 2022 | 59 | 12,574 | 17,865 | $1.3M | $540,442 |
| 2021 | 56 | 12,505 | 18,492 | $1.3M | $560,373 |
| 2020 | 49 | 11,113 | 15,831 | $1.0M | $418,407 |
Total Patients
49,614
Total Services
71,522
Medicare Billing
$2.1M
Procedure Codes
217
All Medicare Procedures & Services
217 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,001 | 2,434 | $304,250 | $189,997 | 62.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 362 | 362 | $103,170 | $100,179 | 97.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 743 | 743 | $118,880 | $89,475 | 75.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 429 | 445 | $33,375 | $31,691 | 95.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 957 | 1,217 | $88,841 | $19,933 | 22.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,043 | 2,245 | $38,165 | $18,834 | 49.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 230 | 256 | $22,528 | $13,829 | 61.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 86 | 86 | $14,190 | $13,240 | 93.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 962 | 1,159 | $66,063 | $11,931 | 18.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 944 | 1,202 | $56,494 | $10,571 | 18.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 444 | 463 | $10,649 | $10,368 | 97.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 773 | 777 | $66,822 | $10,142 | 15.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 954 | 1,294 | $64,700 | $9,790 | 15.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 301 | 327 | $66,054 | $9,419 | 14.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 455 | 923 | $40,612 | $8,761 | 21.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 361 | 361 | $8,303 | $8,092 | 97.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 235 | 235 | $47,000 | $7,958 | 16.9% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 485 | 797 | $36,662 | $6,600 | 18.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 256 | 256 | $26,624 | $4,749 | 17.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 29 | 29 | $4,640 | $4,370 | 94.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 186 | 329 | $14,805 | $4,347 | 29.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 34 | $5,950 | $4,311 | 72.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 218 | 272 | $12,240 | $3,984 | 32.5% |
| 82746 | Folic acid level, serum | Office | 2023 | 216 | 270 | $14,040 | $3,850 | 27.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 68 | 88 | $15,752 | $3,222 | 20.5% |
About Dr. John Bauer, MD
Dr. John Bauer, MD is a Pediatrics healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164474763.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Bauer, MD has received a total of $12,817 in payments from pharmaceutical and medical device companies, with $1,919 received in 2024. These payments were reported across 848 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($12,703).
As a Medicare-enrolled provider, Bauer has provided services to 49,614 Medicare beneficiaries, totaling 71,522 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 217 distinct procedure/service records.
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Internal Medicine
- Location Cape Girardeau, MO
- Active Since 05/16/2006
- Last Updated 01/10/2019
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1164474763
Products in Payments
- UBRELVY (Drug) $2,895
- QULIPTA (Drug) $586.22
- VRAYLAR (Drug) $574.19
- JARDIANCE (Drug) $454.99
- Ozempic (Drug) $418.41
- MOUNJARO (Drug) $347.34
- MYRBETRIQ (Drug) $281.44
- GEMTESA (Drug) $244.92
- Vascepa (Drug) $223.96
- JANUVIA (Drug) $222.50
- Prolia (Biological) $220.96
- ADVAIR (Drug) $213.81
- FREESTYLE LIBRE 2 (Device) $206.00
- TRADJENTA (Drug) $202.92
- FARXIGA (Drug) $199.93
- INJECTAFER (Drug) $196.91
- Veozah (Drug) $188.37
- BREO (Drug) $169.89
- EMGALITY (Drug) $168.29
- XARELTO (Drug) $163.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Cape Girardeau
Dr. Gary Olson, M.d, M.D
Pediatrics — Payments: $3,992
Pediatrics $3,992
Munira Rahman-Anwar, Do, DO
Pediatrics — Payments: $2,404
Pediatrics $2,404
Dr. Karin Barnes, M.d, M.D
Pediatrics — Payments: $807.10
Pediatrics $807.10
Dr. Nefretiti Garrison-North, Md, MD
Pediatrics — Payments: $683.11
Pediatrics $683.11
John Leland, Do, DO
Pediatrics — Payments: $647.53
Pediatrics $647.53
Dr. Chelsea Grigery, M.d, M.D
Pediatrics — Payments: $537.87
Pediatrics $537.87